 The FDA granted 510k clearance to Lensar Incs NASDAQ: LNSR next-generation ALLY Adaptive Cataract Treatment System ALLY System. ALLY is the first FDA-cleared platform to enable cataract surgeons to complete the femtosecond-laser-assisted cataract surgery FLACS. 